Similar Papers

Paper Title
Journal
Date
Author
Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections.
Paul A Baars ... Dieneke Schonenberg-Meinema
Clinical and experimental rheumatology | VOL. 41
Paul A Baars, et. al.Paul A Baars ... Dieneke Schonenberg-Meinema
05 Jan 2023
FRI0339 B cell repopulation kinetics after rituximab treatment in anca-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients
J Thiel ... U Salzer
Annals of the Rheumatic Diseases | VOL. 76
J Thiel, et. al.J Thiel ... U Salzer
01 Jun 2017
B cell repopulation trajectory after rituximab treatment in autoimmune diseases: a longitudinal observational study.
Yuxue Nie ... Yunjiao Yang
Clinical and experimental medicine | VOL. 23
Yuxue Nie, et. al.Yuxue Nie ... Yunjiao Yang
26 Sep 2023
FRI0201 Analysis of infection risk in patients with limited return of peripheral B cells after a period of 2 years or more following any rituximab treatment course in RA clinical trials
P Mease ... P Durez
Annals of the Rheumatic Diseases | VOL. 71
P Mease, et. al.P Mease ... P Durez
01 Jun 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Greetings from the Editor - 2025.
Josef Smolen
Annals of the rheumatic diseases | VOL. 84
Josef SmolenJosef Smolen
01 Jan 2025
Bridging the gap: tackling the challenge of limited progressors in clinical trials aimed at slowing the transition from early preradiographic to established osteoarthritis.
Francis Berenbaum ... Marc Buyse
Annals of the rheumatic diseases | VOL. 84
Francis Berenbaum, et. al.Francis Berenbaum ... Marc Buyse
01 Jan 2025
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.